A proposed change in the medical terminology used for polycystic ovarian syndrome is drawing attention from doctors and women’s health advocates, who say the shift could reshape how the condition is understood beyond fertility and reproductive symptoms.
The condition, long known as PCOS, is now being referred to in medical discussions as polyendocrine metabolic ovarian syndrome, or PMOS. Supporters of the change argue that the new name better reflects the complexity of the disorder and the range of systems it affects in the body.
The revised terminology places emphasis on endocrine and metabolic health, moving away from the narrow association with ovarian cysts that has defined public understanding of the condition for years. For many women, that distinction matters because the illness is often experienced as more than a reproductive disorder.
The healthcare journal The Lancet, which first carried the development, noted that the “historically neglected female condition affects 170 million individuals globally”. The discussion around renaming has since prompted wider conversations among health practitioners about diagnosis, treatment priorities and healthcare policy.
According to gynaecologist Shweta Mendiratta of Yatharth Hospital, the evolution of medical vocabulary can influence how institutions respond to a disease.
“The evolution of medical vocabulary throughout time can affect health policy, especially if it modifies the way an illness is recognised and interpreted by health care institutions,” she said.
Mendiratta said formally classifying PMOS as both a metabolic and endocrine illness could push health systems to pay greater attention to early screening for insulin resistance, obesity, cardiovascular risks and mental health concerns.
She added that hospital guidelines, insurance systems, public health programmes and medical education frameworks may eventually be updated to reflect what she described as the “larger impact” of the disease.
In India, conversations around PCOS — and now PMOS — have often remained closely tied to fertility and menstrual health. One of the most widely used treatment approaches involves birth control pills to regulate irregular periods, a symptom commonly associated with the condition.
That focus, doctors and women living with the disorder have argued in recent years, can sometimes leave broader health complications in the background. The proposed renaming has therefore been received by some as an attempt to widen both medical and public understanding of the condition.
Also Read:
vivo X300 Ultra Arrives in Market With New Victory Green Finish
For many practitioners, the discussion is not only about terminology. It also reflects a larger effort to frame women’s health conditions in ways that acknowledge their long-term physical and metabolic effects, rather than limiting them to reproductive outcomes alone.
